TrialCancer immunology, immunotherapy : CII2014

Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer.

Moon Jae Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.